Conditions: Overactive Bladder Neurogenic Detrusor Overactivity
Keywords: Study of fesoterodine in pediatric overactive bladder patients
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 21
Healthy volunteers: no

Brief summary:
The purpose of the study is to evaluate the pharmacokinetics, safety, and tolerability of fesoterodine following administration to pediatric patients, aged 8-17 years, with overactive bladder.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Fesoterodine
Intervention descriptions: intervention 1: 4 mg once daily for Weeks 1-4 and 8 mg once daily for Weeks 5-8

Protocol document: